A phase II randomised trial of 5-fluorouracil with or without interferon alpha-2a in advanced colorectal cancer.

With the association of 5-fluorouracil (5-FU) and alpha-interferon (IFN), objective responses as high as 26 63% have been reported in untreated patients with advanced colorectal cancer. However, grade 3-4 toxicity has also been reported. We have conducted a prospective phase II randomised study comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Piga, A., Cascinu, S., Latini, L., Marcellini, M., Bavosi, M., Acito, L., Bascioni, R., Giustini, L., Francini, G., Pancotti, A., Rossi, G., Del Papa, M., Carle, F., Cellerino, R.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074731/
https://www.ncbi.nlm.nih.gov/pubmed/8826868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074731/
https://www.ncbi.nlm.nih.gov/pubmed/8826868

Ejemplares similares